Guanylate Cyclases Inhibitors
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BPIPP | 325746-94-9 | sc-203852 sc-203852A | 10 mg 50 mg | $189.00 $797.00 | 1 | |
BPIPP acts as a potent modulator of guanylate cyclases, engaging in specific interactions that enhance the conversion of GTP to cGMP. Its structural features promote a unique binding affinity, optimizing enzyme conformation for increased catalytic activity. The compound's ability to influence reaction kinetics is notable, as it alters the rate of cGMP production, thereby impacting downstream signaling pathways. Additionally, BPIPP's diverse functional groups facilitate interactions with lipid membranes, potentially affecting cellular compartmentalization and signaling dynamics. | ||||||
2-Chloroadenosine triphosphate sodium salt | 49564-60-5 | sc-288070 | 5 µmol | $357.00 | 1 | |
2-Chloroadenosine triphosphate sodium salt serves as a significant activator of guanylate cyclases, exhibiting a unique ability to stabilize enzyme-substrate complexes. Its distinct molecular structure allows for enhanced specificity in binding, which accelerates the conversion of GTP to cGMP. This compound also influences allosteric sites, modulating enzyme activity and altering the dynamics of intracellular signaling cascades. Furthermore, its ionic nature may enhance solubility and membrane permeability, impacting cellular interactions. | ||||||
AG-1288 | 116313-73-6 | sc-200664 sc-200664A | 10 mg 50 mg | $60.00 $311.00 | ||
AG-1288 functions as a potent modulator of guanylate cyclases, characterized by its ability to selectively interact with specific receptor sites. This compound promotes the formation of cGMP through a unique mechanism that involves the stabilization of transition states during the catalytic process. Its structural features facilitate rapid reaction kinetics, allowing for efficient signal transduction. Additionally, AG-1288's hydrophilic properties enhance its interaction with cellular membranes, influencing downstream signaling pathways. | ||||||
NS 2028 | 204326-43-2 | sc-202743 | 5 mg | $149.00 | 1 | |
NS 2028 acts as a selective modulator of guanylate cyclases, distinguished by its unique binding affinity for allosteric sites on the enzyme. This compound enhances cGMP synthesis by promoting conformational changes that optimize enzyme activity. Its kinetic profile reveals a remarkable rate of activation, contributing to robust signaling cascades. Furthermore, NS 2028's lipophilic characteristics enable effective membrane penetration, impacting cellular response mechanisms. | ||||||